Journal of Nuclear Medicine

Title Publication Date Language Citations
Processing of Generator-Produced 68Ga for Medical Application2007/10/01English368
PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles2008/07/16English360
Benefit of Time-of-Flight in PET: Experimental and Clinical Results2008/02/20English353
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy2016/01/21English351
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer2007/12/12English350
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT2017/11/09English346
Multimodality Molecular Imaging of Tumor Angiogenesis2008/06/01English345
Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations2008/05/15English339
The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience2012/01/06English338
Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary Hypertension2007/05/01English335
Molecular Imaging of Hypoxia2008/06/01English331
18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort2014/12/11English327
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding2017/04/13English325
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting2007/05/01English325
MRI-Based Attenuation Correction for PET/MRI Using Ultrashort Echo Time Sequences2010/05/01English324
Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain2009/10/16English320
MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration2008/10/16English318
MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy2010/01/15English312
Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods2012/11/19English307
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo2010/07/21English306
Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis2007/10/01English305
A Novel Method of 18F Radiolabeling for PET2009/05/14English299
Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?2012/11/30English295
PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications2010/02/11English289
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions2015/08/20English288
Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG2012/01/01English286
Performance Characteristics of the Digital Biograph Vision PET/CT System2019/01/10English283
Clinical Diagnosis and Management of Breast Cancer2016/02/01English281
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma2015/10/08English276
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control2018/01/11English276